ATRA Stock Analysis: Buy, Sell, or Hold?
ATRA - Atara Biotherapeutics, Inc
$11.16
0.55 (5.18%)
▲
5d:
+12.05%
30d:
+19.49%
90d:
+130.34%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When ATRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ATRA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ATRA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$31.14
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$19.34
42.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ATRA is currently trading at $11.16, which is considered extended relative to its 30-day fair value range of $9.47 to $10.52. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.3) compared to its historical average (17.5). Remarkably, the market is currently pricing in an annual earnings decline of 21.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ATRA is in a strong uptrend. Immediate support is located at $9.21, while resistance sits at $11.55. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.67 (+28.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ATRA is in a strong uptrend. Immediate support is located at $9.21, while resistance sits at $11.55. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.67 (+28.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.47 -
$10.52
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.0%
All Signals
- BEARISH: Price extended above range (+6.1% above its trading range)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.2%)
- BULLISH: Trading 28.8% below Wall St target ($13.67)
Trading Range Analysis
30-Day Trading Range
$9.47 -
$10.52
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.21
Resistance Level
$11.55
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.35
Wall Street Target
$13.67
(+28.8%)
Revenue Growth (YoY)
-99.5%
Profit Margin
-40.9%
Valuation Discount vs History
-21.8% cheaper
PE vs Historical
8.4 vs 17.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-21.8%
(market-implied from PE analysis)
1-Year Target
$9.55
(-10%)
2-Year Target
$8.59
(-19%)
3-Year Target
$7.73
(-27%)
3-Yr Target (if PE normalizes)
(PE: 8→18)
$16.20
(+53%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.4 to 17.5
Stabilization Target:
$22.22
(+109.5%)
PE Expansion Potential:
+109.5%
Share & Embed Analysis
Last updated: June 23, 2026 4:38 PM ET
Data refreshes hourly during market hours. Next update: 5:38 PM
Data refreshes hourly during market hours. Next update: 5:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Innovation Ltd Panacea
SELL
80554 shares
2026-01-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 62 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 55 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 57 HOLD |
